mogroside IV
CAS No. 89590-95-4
mogroside IV ( —— )
产品货号. M20764 CAS No. 89590-95-4
Mogrosides IV is a sweet minor cucurbitane glycoside it exhibits maltase inhibitory effect(IC50 : 10 mM) and with antioxidant antidiabetic and anticancer activities.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1175 | 有现货 |
|
10MG | ¥2017 | 有现货 |
|
25MG | ¥3912 | 有现货 |
|
50MG | ¥5144 | 有现货 |
|
100MG | ¥6950 | 有现货 |
|
500MG | ¥13932 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称mogroside IV
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Mogrosides IV is a sweet minor cucurbitane glycoside it exhibits maltase inhibitory effect(IC50 : 10 mM) and with antioxidant antidiabetic and anticancer activities.
-
产品描述Mogrosides IV is a sweet minor cucurbitane glycoside it exhibits maltase inhibitory effect(IC50 : 10 mM) and with antioxidant antidiabetic and anticancer activities.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体maltase
-
研究领域——
-
适应症——
化学信息
-
CAS Number89590-95-4
-
分子量1125.31
-
分子式C54H92O24
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES[H][C@@]12CC[C@H](O[C@@H]3O[C@H](CO[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)C(C)(C)C1=CC[C@]1([H])[C@]3(C)CC[C@H]([C@H](C)CC[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)O)[C@@]3(C)C[C@@H](O)[C@@]21C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Suzuki Y A Yuji M Hiroshi I et al. Triterpene glycosides of Siraitia grosvenori inhibit rat intestinal maltase and suppress the rise in blood glucose level after a single oral administration of maltose in rats[J]. Journal of Agricultural & Food Chemistry 2005 53(8):2941-6.
产品手册
关联产品
-
ML355
ML355, a specific, effective 12-Lipoxygenase(12-LOX) inhibitors(IC50=0.34 μM), possess favorable ADME properties.
-
SCS
SCS a potent selective inhibitor of α2β1γ1θ GABA(A) receptors with a maximum inhibition of 56+/-5% and an IC50 of 32 nM.
-
Indicine N-oxide
Indicine N-oxide (NSC 132319), a pyrrolizidine alkaloid, is an antitumor agent for pediatric cancer and solid tumors research.